Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Article

Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use

Michael W. Kuzniewicz, Gabriel J. Escobar and Thomas B. Newman
Pediatrics October 2009, 124 (4) 1031-1039; DOI: https://doi.org/10.1542/peds.2008-2980
Michael W. Kuzniewicz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel J. Escobar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas B. Newman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Abstract

OBJECTIVE: The goal was to assess the impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.

METHODS: In this retrospective cohort study of 358086 infants of ≥35 weeks and ≥2000 g born between January 1, 1995, and June 30, 2007, we obtained demographic data, bilirubin levels, and codes for inpatient phototherapy from existing databases. We compared the incidence of high total serum bilirubin (TSB) levels and phototherapy before and after implementation of universal screening and examined risk factors for high TSB levels.

RESULTS: A total of 38182 infants (10.6%) were born at facilities that had implemented universal bilirubin screening. Compared with infants born at facilities that were not screening, these infants had a 62% lower incidence of TSB levels exceeding the American Academy of Pediatrics exchange guideline (0.17% vs 0.45%; P < .001), received twice the inpatient phototherapy (9.1% vs 4.2%; P < .001), and had slightly longer birth hospitalization lengths of stay (50.9 vs 48.7 hours; P < .001). Of those receiving phototherapy, 56% after initiation of universal screening had TSB levels at which phototherapy was recommended by the guideline, compared with 70% before screening. The adjusted odds ratio for developing TSB levels exceeding the guideline value was 0.28 (95% confidence interval: 0.20–0.40) for those born at a facility using TSB screening and 0.28 (95% confidence interval: 0.19–0.42) for those born at a facility using transcutaneous bilirubin screening.

CONCLUSIONS: Universal bilirubin screening was associated with a significantly lower incidence of severe hyperbilirubinemia but also with increased phototherapy use.

  • bilirubin
  • jaundice
  • newborn
  • phototherapy
  • screening
  • Accepted March 31, 2009.
  • Copyright © 2009 by the American Academy of Pediatrics

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 124, Issue 4
October 2009
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
Michael W. Kuzniewicz, Gabriel J. Escobar, Thomas B. Newman
Pediatrics Oct 2009, 124 (4) 1031-1039; DOI: 10.1542/peds.2008-2980

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of Universal Bilirubin Screening on Severe Hyperbilirubinemia and Phototherapy Use
Michael W. Kuzniewicz, Gabriel J. Escobar, Thomas B. Newman
Pediatrics Oct 2009, 124 (4) 1031-1039; DOI: 10.1542/peds.2008-2980
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Neonatal Indirect Hyperbilirubinemia
  • Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care
  • Hyperbilirubinemia, Phototherapy, and Childhood Asthma
  • Use of a Smartphone App to Assess Neonatal Jaundice
  • Risk of Autism Associated With Hyperbilirubinemia and Phototherapy
  • Neonatal Phototherapy and Infantile Cancer
  • A Model for Predicting Significant Hyperbilirubinemia in Neonates From China
  • Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds
  • Managing the jaundiced newborn: a persistent challenge
  • Early Discharge of Infants and Risk of Readmission for Jaundice
  • Overdiagnosis: How Our Compulsion for Diagnosis May Be Harming Children
  • Universal Bilirubin Screening and Health Care Utilization
  • Incidence, Etiology, and Outcomes of Hazardous Hyperbilirubinemia in Newborns
  • The Intersection of Evidence and Values in Clinical Guidelines: Who Decides What Constitutes Acceptable Risk in the Care of Children?
  • Trends of Transcutaneous Bilirubin in Neonates Who Develop Significant Hyperbilirubinemia
  • Clinician Adherence to Guideline for Phototherapy Use in Newborns
  • Fluorescence Sensor for the Quantification of Unbound Bilirubin Concentrations
  • International Perspectives: Neonatal Jaundice: Building a Culture of Safety (An Argentinean Perspective)
  • Impact of a Transcutaneous Bilirubinometry Program on Resource Utilization and Severe Hyperbilirubinemia
  • Care of the Well Newborn
  • Evidence Suggests There Was Not a "Resurgence" of Kernicterus in the 1990s
  • Prospective Validation of a Novel Strategy for Assessing Risk of Significant Hyperbilirubinemia
  • Screening for Hyperbilirubinemia in Infants
  • Hyperbilirubinemia in the Newborn Infant >=35 Weeks' Gestation: An Update With Clarifications
  • Universal Bilirubin Screening, Guidelines, and Evidence
  • Google Scholar

More in this TOC Section

  • Relational, Emotional, and Pragmatic Attributes of Ethics Consultations at a Children’s Hospital
  • Verbal Autopsies for Out-of-Hospital Infant Deaths in Zambia
  • Uncertainty at the Limits of Viability: A Qualitative Study of Antenatal Consultations
Show more Articles

Similar Articles

Subjects

  • Fetus/Newborn Infant
    • Fetus/Newborn Infant
    • Hyperbilirubinemia
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics